2022 BioTech Blog Drug Development 
Society for Participatory Medicine
FEBRUARY 1, 2023
Flash back to my article for the Society for Participatory Medicine last year: Let’s Save the Date and Make Patient Engagement Official in 2022. The FDA issued a series of four patient-focused drug development (PFDD) guidance documents which outline how patient co-design needs to successfully happen.
Society for Participatory Medicine
JANUARY 27, 2022
Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and life sciences firms, and insurance companies serve patients as end users. And I propose a toast: “To stop talking about involving patients and actually do it in 2022. How do we get the patient to actually be the one improving patient experience?
Expert insights. Personalized for you.
144 
Let's personalize your content